CCN2 p.Gly100Ser
c.298G>A · VCV3487313
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1642 | likely benign |
|---|---|---|
| REVEL | 0.598 | indeterminate |
| SaProt | LLR -10.16 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 2.8, phastCons 1 |
| Regional constraint | o/e 0.94 | unconstrained · MANE · 1,905 bp · p 0.18 · regional, not allelic |
| Overall | ||
| CADD | 28.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CCN2
- Protein
- p.Gly100Ser
- Coding
- c.298G>A
- MANE Select
- NM_001901
- Type
- single nucleotide variant
- Location
- chr6:131950535 (GRCh38)
- Gene constraint
- LOEUF 1.05 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 78.43
Similar variants
- CCN2 p.Gly100Ala Uncertain significance ★ ⚠ same residue
- CCN2 c.290-6C>T Benign ★★ same type
- CCN2 c.67-4G>A Likely benign ★★ same type
- CCN2 p.Ala101Ser Uncertain significance ★ ⚠ same type
- CCN2 p.Ala208Thr Uncertain significance ★ ⚠ same type
- CCN2 p.Ala45Val Uncertain significance ★ ⚠ same type
- CCN2 p.Ala61Thr Uncertain significance ★ ⚠ same type
- CCN2 p.Arg34Gly Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ccn2-p-gly100ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown